FINWIRES · TerminalLIVE
FINWIRES

Verisk Analytics第一季度调整后盈利和营收均有所增长;2026年展望维持不变

By

-- Verisk Analytics (VRSK) 周三公布了第一季度调整后每股收益为 1.82 美元,高于去年同期的 1.73 美元。 FactSet 调查的分析师此前预期为 1.74 美元。 截至 3 月 31 日的第一季度营收为 7.826 亿美元,高于去年同期的 7.53 亿美元。 FactSet 调查的分析师此前预期为 7.716 亿美元。 该公司重申了 2026 年调整后每股收益预期,为 7.45 美元至 7.75 美元。FactSet 调查的分析师此前预期为 7.62 美元。 该公司预计全年营收仍为 31.9 亿美元至 32.4 亿美元。FactSet 调查的分析师此前预期为 32.1 亿美元。 该公司股价周三盘前上涨超过 3%。

Price: $182.00, Change: $+5.34, Percent Change: +3.02%

Related Articles

Australia

Mizuho Securities Raises Price Target on Apellis Pharmaceuticals to $41 From $20, Maintains Neutral Rating

Apellis Pharmaceuticals (APLS) has an average rating of hold and mean price target of $40.82, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $40.95, Change: $-0.05, Percent Change: -0.11%

$APLS
Research

Mizuho Securities Downgrades Terns Pharmaceuticals to Neutral From Outperform, Trims Price Target to $53 From $54

Terns Pharmaceuticals (TERN) has an average rating of hold and mean price target of $53, according to analysts polled by FactSet.

$TERN
Research

Research Alert: CFRA Reiterates Buy Opinion On Shares Of Booking Holdings Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target price by $8 to $196, 19x our 2026 EPS estimate (unchanged) and a discount to its 23x five-year average forward multiple, reflecting geopolitical risks. We lower our 2026 EPS to $10.33 from $10.74 and 2027's to $11.58 from $12.07, primarily reflecting lower gross bookings growth from the Middle East conflict. We maintain our Buy opinion as shares are undervalued given long-term competitive strengths and temporary geopolitical headwinds. The company's Connected Trip platform and Genius loyalty program are supporting higher-margin direct bookings, suggesting AI initiatives are strengthening consumer engagement rather than disintermediating the platform. Strong free cash flow supports future shareholder returns, including $3.6 billion in Q1 buybacks. While the Middle East conflict will impact Q2 bookings, BKNG has a history of seeing travel rebound following geopolitical or economic disruptions. U.S. room night growth accelerated in Q1 to a low-teens range, providing near-term momentum.

$BKNG